524768 — Emmessar Biotech and Nutrition Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹179.36m
- IN₹110.47m
- IN₹5.55m
- 39
- 12
- 30
- 13
Annual cashflow statement for Emmessar Biotech and Nutrition, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 10 | 22.5 | 9.31 | 9.67 | 8.13 |
| Depreciation | |||||
| Non-Cash Items | -3.68 | -1.3 | -2.19 | -2.48 | -5.22 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.4 | -17.1 | 14.7 | -4.36 | 2.56 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 10.3 | 4.68 | 22.7 | 3.76 | 6.45 |
| Capital Expenditures | -0.005 | -0.018 | -3.06 | -0.263 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -10.6 | 0.1 | -23.1 | -5.2 | -6.43 |
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -10.6 | 0.082 | -26.1 | -5.46 | -6.43 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.273 | 4.76 | -3.45 | -1.7 | 0.01 |